Tuberculosis 2016 - Supplementary tables

Subscribe to CCDR

Submit a manuscript

About CCDR

Browse

Past issues

Volume 44-3/4, March 1, 2018: Can we eliminate tuberculosis?

Web exclusive

Tuberculosis in Canada, 2016 – Supplementary Tables

J Vachon¹, V Gallant¹, W Siu¹

Affiliation

¹ Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, On

Correspondence

TB_Surveillance@phac-aspc.gc.ca

Suggested citation

Vachon J, Gallant V, Siu W. Tuberculosis 2016 – Supplementary Tables. Web exclusive. Can Commun Dis Rep. 2018;44(3/4).

Introduction

This article provides supplementary data for the surveillance report in this issue entitled: Tuberculosis in Canada, 2016.^{Footnote 1}

National case definitions for confirmed cases of tuberculosis and new and re-treatment cases^{Footnote 2}

Confirmed case

Laboratory confirmed case

Cases with Mycobacterium tuberculosis complex demonstrated on culture, specifically M. tuberculosis, M. africanum, M. canetti, M. caprae, M. microti, M. pinnipedii or M. bovis (excluding M. bovis BCG strain).

Clinically confirmed case

In the absence of culture proof, cases clinically compatible with active tuberculosis (TB) that have, for example:

chest x-ray changes compatible with active tuberculosis;
active nonrespiratory tuberculosis (meningeal, bone, kidney, peripheral lymph nodes, etc.);
pathologic or post-mortem evidence of active tuberculosis;
favourable response to therapeutic trial of antituberculosis drugs.

New and re-treatment cases of tuberculosis

New case

No documented evidence or adequate history of previously active tuberculosis.

Re-treatment case

Documented evidence or adequate history of previously active TB which was declared cured or treatment completed by current standards
At least six months have passed since the last day of previous treatment
Diagnosed with a subsequent episode of TB which meets the active TB case definition

OR

Documented evidence or adequate history of previously active TB which cannot be declared cured or treatment completed by current standards
Inactive for six months or longer after the last day of previous treatment
Diagnosed with a subsequent episode of TB which meets the active TB case definition

Table 1A: Reported new active and re-treatment tuberculosis cases and incidence rate per 100,000 population (all cases) – Canada and provinces/territories: 2006–2016^{Footnote a}
Reporting year		Canada	Province/Territory
Reporting year		Canada	N.L.	P.E.I.	N.S.	N.B.	Que.	Ont.	Man.	Sask.	Alta.	B.C.	Y.T.	N.W.T.	Nvt.
2006	Cases	1,653	12	0	10	2	227	673	134	87	131	320	3	6	48
2006	Rate	5.1	2.4	0.0	1.1	0.3	3.0	5.3	11.3	8.8	3.8	7.5	9.3	13.9	155.8
2007	Cases	1,575	7	0	7	5	229	680	103	105	112	278	3	15	31
2007	Rate	4.8	1.4	0.0	0.7	0.7	3.0	5.3	8.7	10.5	3.2	6.5	9.2	34.6	98.7
2008	Cases	1,642	8	0	5	5	240	598	141	97	167	300	8	14	59
2008	Rate	4.9	1.6	0.0	0.5	0.7	3.1	4.6	11.8	9.5	4.6	6.9	24.2	32.3	185.0
2009	Cases	1,654	22	1	8	11	196	629	156	90	176	294	4	12	55
2009	Rate	4.9	4.3	0.7	0.9	1.5	2.5	4.8	12.9	8.7	4.8	6.7	11.9	27.8	168.7
2010	Cases	1,587	8	1	10	10	210	643	131	81	134	242	6	11	100
2010	Rate	4.7	1.5	0.7	1.1	1.3	2.6	4.9	10.7	7.7	3.6	5.4	17.3	25.4	299.8
2011	Cases	1,621	8	3	9	5	217	658	116	83	170	261	4	13	74
2011	Rate	4.7	1.5	2.1	1.0	0.7	2.7	5.0	9.4	7.8	4.5	5.8	11.3	29.9	216.4
2012	Cases	1,700	4	1	8	5	271	618	136	89	195	286	1	6	80
2012	Rate	4.9	0.8	0.7	0.8	0.7	3.4	4.6	10.9	8.2	5.0	6.3	2.8	13.8	230.5
2013	Cases	1,651	13	0	8	3	240	634	166	86	187	257	2	4	51
2013	Rate	4.7	2.5	0.0	0.8	0.4	2.9	4.7	13.1	7.8	4.7	5.6	5.5	9.1	144.1
2014	Cases	1,614	7	3	7	5	207	585	135	88	217	268	4	4	84
2014	Rate	4.5	1.3	2.1	0.7	0.7	2.5	4.3	10.5	7.8	5.3	5.8	10.8	9.1	233.2
2015	Cases	1,642	33	3	6	6	244	597	158	70	210	263	3	5	44
2015	Rate	4.6	6.2	2.0	0.6	0.8	3.0	4.3	12.2	6.2	5.0	5.6	8.0	11.3	120.4
2016	Cases	1,737	28	4	2	13	250	633	201	91	238	220	1	3	53
2016	Rate	4.8	5.3	2.7	0.2	1.7	3.0	4.5	15.2	7.9	5.6	4.6	2.7	6.7	142.9
Abbreviations: Alta., Alberta; B.C., British Columbia; Man., Manitoba; N.B., New Brunswick; N.L., Newfoundland and Labrador; N.S., Nova Scotia; Nvt., Nunavut; N.W.T., Northwest Territories; Ont., Ontario; P.E.I., Prince Edward Island; Que., Quebec; Sask., Saskatchewan; Y.T., Yukon Table 1A Footnote a Source of denominator values for rate calculation: Statistics Canada, Demography Division, Demographic Estimates Section, July Population Estimates, 2006-2016 Updated postcensal estimates (Accessed 2017-10-18) Return to footnote a referrer

Table 1B: Reported new active and re-treatment tuberculosis cases and incidence rate per 100,000 population (males) – Canada and provinces/territories: 2006–2016^{Footnote a}
Reporting year		Canada	Province/Territory
Reporting year		Canada	N.L.	P.E.I.	N.S.	N.B.	Que.	Ont.	Man.	Sask.	Alta.	B.C.	Y.T.	N.W.T.	Nvt.
2006	Cases	882	3	0	7	0	122	361	79	50	63	162	3	4	28
2006	Rate	5.5	1.2	0.0	1.5	0.0	3.2	5.8	13.4	10.2	3.6	7.7	18.2	17.8	176.0
2007	Cases	864	3	0	2	4	131	351	62	62	57	163	2	12	15
2007	Rate	5.3	1.2	0.0	0.4	1.1	3.4	5.6	10.5	12.5	3.2	7.7	12.0	53.3	92.4
2008	Cases	886	3	0	3	3	130	311	86	46	89	161	5	9	40
2008	Rate	5.4	1.2	0.0	0.7	0.8	3.4	4.9	14.5	9.1	4.9	7.5	29.5	40.2	241.7
2009	Cases	917	12	0	3	4	119	344	87	46	93	169	4	8	28
2009	Rate	5.5	4.7	0.0	0.7	1.1	3.1	5.4	14.5	8.9	5.0	7.7	23.2	36.0	165.8
2010	Cases	865	6	0	5	6	120	335	71	42	76	123	4	8	69
2010	Rate	5.1	2.3	0.0	1.1	1.6	3.1	5.2	11.7	8.0	4.0	5.5	22.6	36.0	399.8
2011	Cases	882	5	2	4	2	139	326	57	45	88	157	1	8	48
2011	Rate	5.2	1.9	2.8	0.9	0.5	3.5	5.0	9.3	8.4	4.6	7.0	5.5	35.8	271.1
2012	Cases	994	1	1	6	3	150	338	72	61	118	186	1	3	54
2012	Rate	5.8	0.4	1.4	1.3	0.8	3.7	5.1	11.6	11.2	6.0	8.2	5.4	13.4	300.9
2013	Cases	903	7	0	6	0	127	344	98	47	99	138	1	3	33
2013	Rate	5.2	2.7	0.0	1.3	0.0	3.1	5.2	15.6	8.4	4.9	6.1	5.4	13.4	180.2
2014	Cases	908	4	2	6	2	134	328	64	51	120	150	1	2	44
2014	Rate	5.2	1.5	2.8	1.3	0.5	3.3	4.9	10.1	9.0	5.7	6.5	5.3	8.9	236.2
2015	Cases	870	20	0	5	5	142	321	72	35	109	122	2	3	34
2015	Rate	4.9	7.7	0.0	1.1	1.3	3.5	4.7	11.2	6.1	5.1	5.2	10.5	13.3	180.1
2016	Cases	943	21	2	1	7	139	333	116	45	130	119	1	2	27
2016	Rate	5.2	8.0	2.8	0.2	1.9	3.4	4.8	17.7	7.8	6.0	5.0	5.2	8.8	140.9
Abbreviations: Alta., Alberta; B.C., British Columbia; Man., Manitoba; N.B., New Brunswick; N.L., Newfoundland and Labrador; N.S., Nova Scotia; Nvt., Nunavut; N.W.T., Northwest Territories; Ont., Ontario; P.E.I., Prince Edward Island; Que., Quebec; Sask., Saskatchewan; Y.T., Yukon Table 1B Footnote a Source of denominator values for rate calculation: Statistics Canada, Demography Division, Demographic Estimates Section, July Population Estimates, 2006-2016 Updated postcensal estimates (Accessed 2017-10-18) Return to footnote a referrer

Table 1C: Reported new active and re-treatment tuberculosis cases and incidence rate per 100,000 population (females) – Canada and provinces/territories: 2006–2016^{Footnote a}
Reporting year		Canada	Province/Territory
Reporting year		Canada	N.L.	P.E.I.	N.S.	N.B.	Que.	Ont.	Man.	Sask.	Alta.	B.C.	Y.T.	N.W.T.	Nvt.
2006	Cases	771	9	0	3	2	105	312	55	37	68	158	0	2	20
2006	Rate	4.7	3.5	0.0	0.6	0.5	2.7	4.9	9.2	7.4	4.0	7.4	0.0	9.7	134.2
2007	Cases	711	4	0	5	1	98	329	41	43	55	115	1	3	16
2007	Rate	4.3	1.5	0.0	1.0	0.3	2.5	5.1	6.8	8.5	3.2	5.3	6.3	14.4	105.5
2008	Cases	756	5	0	2	2	110	287	55	51	78	139	3	5	19
2008	Rate	4.5	1.9	0.0	0.4	0.5	2.8	4.4	9.1	10.0	4.4	6.3	18.6	23.9	123.8
2009	Cases	737	10	1	5	7	77	285	69	44	83	125	0	4	27
2009	Rate	4.3	3.8	1.4	1.0	1.8	1.9	4.3	11.3	8.5	4.6	5.6	0.0	19.1	171.9
2010	Cases	722	2	1	5	4	90	308	60	39	58	119	2	3	31
2010	Rate	4.2	0.8	1.4	1.0	1.0	2.3	4.6	9.8	7.4	3.2	5.3	11.8	14.3	192.6
2011	Cases	739	3	1	5	3	78	332	59	38	82	104	3	5	26
2011	Rate	4.3	1.1	1.4	1.0	0.8	1.9	4.9	9.5	7.1	4.4	4.6	17.3	23.6	157.7
2012	Cases	706	3	0	2	2	121	280	64	28	77	100	0	3	26
2012	Rate	4.0	1.1	0.0	0.4	0.5	3.0	4.1	10.2	5.2	4.0	4.4	0.0	14.1	155.1
2013	Cases	748	6	0	2	3	113	290	68	39	88	119	1	1	18
2013	Rate	4.2	2.2	0.0	0.4	0.8	2.8	4.2	10.7	7.1	4.5	5.2	5.6	4.7	105.3
2014	Cases	706	3	1	1	3	73	257	71	37	97	118	3	2	40
2014	Rate	3.9	1.1	1.3	0.2	0.8	1.8	3.7	11.0	6.7	4.8	5.0	16.6	9.3	230.0
2015	Cases	772	13	3	1	1	102	276	86	35	101	141	1	2	10
2015	Rate	4.3	4.8	4.0	0.2	0.3	2.5	3.9	13.2	6.2	4.9	6.0	5.4	9.2	56.6
2016	Cases	794	7	2	1	6	111	300	85	46	108	101	0	1	26
2016	Rate	4.3	2.6	2.6	0.2	1.6	2.7	4.2	12.8	8.1	5.2	4.2	0.0	4.6	145.1
Abbreviations: Alta., Alberta; B.C., British Columbia; Man., Manitoba; N.B., New Brunswick; N.L., Newfoundland and Labrador; N.S., Nova Scotia; Nvt., Nunavut; N.W.T., Northwest Territories; Ont., Ontario; P.E.I., Prince Edward Island; Que., Quebec; Sask., Saskatchewan; Y.T., Yukon Table 1C Footnote a Source of denominator values for rate calculation: Statistics Canada, Demography Division, Demographic Estimates Section, July Population Estimates, 2006-2016 Updated postcensal estimates (Accessed 2017-10-18) Return to footnote a referrer

Table 2: Reported new active and re-treatment tuberculosis cases and incidence rates per 100,000, by age group – Canada: 2006–2016^{Footnote a}
Reporting year		Canada	Age group
Reporting year		Canada	<1	1–4	5–14	15–24	25–34	35–44	45–54	55–64	65–74	75+
2006	Cases	1,653	10	46	50	261	253	287	201	158	168	219
2006	Rate	5.1	2.9	3.3	1.3	5.8	5.8	5.7	4.0	4.3	7.4	10.8
2007	Cases	1,575	12	33	53	200	254	284	209	160	152	218
2007	Rate	4.8	3.3	2.4	1.4	4.5	5.8	5.7	4.0	4.2	6.5	10.5
2008	Cases	1,642	8	30	50	204	298	281	231	166	170	204
2008	Rate	4.9	2.1	2.1	1.3	4.5	6.7	5.8	4.4	4.2	7.1	9.6
2009	Cases	1,654	10	33	46	232	297	294	232	177	142	191
2009	Rate	4.9	2.6	2.3	1.2	5.1	6.5	6.2	4.3	4.3	5.7	8.8
2010	Cases	1,587	9	27	39	201	283	272	214	176	149	217
2010	Rate	4.7	2.4	1.8	1.0	4.4	6.1	5.8	4.0	4.1	5.8	9.8
2011	Cases	1,621	13	33	40	216	297	251	224	168	173	206
2011	Rate	4.7	3.5	2.2	1.1	4.7	6.3	5.4	4.1	3.8	6.4	9.1
2012	Cases	1,700	9	50	54	239	296	269	234	155	178	216
2012	Rate	4.9	2.4	3.3	1.4	5.2	6.2	5.8	4.4	3.4	6.3	9.3
2013	Cases	1,651	13	38	61	209	269	244	238	189	169	221
2013	Rate	4.7	3.4	2.5	1.6	4.5	5.6	5.2	4.5	4.1	5.6	9.3
2014	Cases	1,614	11	33	33	196	288	241	222	197	162	231
2014	Rate	4.5	2.9	2.1	0.9	4.3	5.9	5.1	4.2	4.2	5.1	9.5
2015	Cases	1,642	10	40	46	196	280	247	211	188	174	250
2015	Rate	4.6	2.6	2.6	1.2	4.3	5.6	5.2	4.1	3.9	5.3	10.0
2016	Cases	1,737	8	39	39	228	338	242	202	194	180	267
2016	Rate	4.8	2.0	2.5	1.0	5.0	6.7	5.0	3.9	3.9	5.3	10.4
Table 2 Footnote a Source of denominator values for rate calculation: Statistics Canada, Demography Division, Demographic Estimates Section, July Population Estimates, 2006–2016 Updated postcensal estimates (Accessed 2017–10–18) Return to footnote a referrer

Table 3: Reported new active and re-treatment tuberculosis cases and incidence rate per 100,000 population, by age group – Canada and provinces/territories: 2016^{Footnote a}
Age group		Canada	Province/Territory
Age group		Canada	N.L.	P.E.I.	N.S.	N.B.	Que.	Ont.	Man.	Sask.	Alta.	B.C.	Y.T.	N.W.T.	Nvt.
<1	Cases	8	0	0	0	0	2	2	1	0	1	0	0	0	2
<1	Rate	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2
1–4	Cases	39	0	0	0	1	5	6	14	4	4	1	0	0	4
1–4	Rate	2.5	0.0	0.0	0.0	3.5	1.4	1.0	20.7	6.5	1.8	0.6	0.0	0.0	123.5
5–14	Cases	39	0	0	0	1	7	4	14	4	2	2	0	0	5
5–14	Rate	1.0	0.0	0.0	0.0	1.3	0.8	0.3	8.6	2.8	0.4	0.4	0.0	0.0	68.7
15–24	Cases	228	10	1	1	2	43	75	39	10	18	15	0	1	13
15–24	Rate	5.0	17.5	5.4	0.9	2.3	4.5	4.1	21.5	6.7	3.4	2.5	0.0	16.1	202.7
25–34	Cases	338	9	0	1	1	52	118	42	19	52	37	0	0	7
25–34	Rate	6.7	14.1	0.0	0.8	1.2	4.7	6.1	22.5	10.9	7.3	5.7	0.0	0.0	111.2
35–44	Cases	242	4	1	0	2	46	70	26	13	49	21	1	2	7
35–44	Rate	5.0	6.0	5.6	0.0	2.1	4.1	3.9	15.6	9.0	7.8	3.4	17.5	30.6	151.0
45–54	Cases	202	2	1	0	1	21	74	24	17	28	27	0	0	7
45–54	Rate	3.9	2.4	4.5	0.0	0.9	1.8	3.6	13.9	11.8	4.9	4.0	0.0	0.0	169.8
55–64	Cases	194	0	0	0	0	22	77	21	13	30	27	0	0	4
55–64	Rate	3.9	0.0	0.0	0.0	0.0	1.8	4.1	12.7	8.9	5.8	4.0	0.0	0.0	144.0
65–74	Cases	180	1	1	0	1	22	85	10	5	19	32	0	0	4
65–74	Rate	5.3	1.6	5.9	0.0	1.2	2.6	6.6	9.0	5.5	6.4	6.6	0.0	0.0	351.5
75+	Cases	267	2	0	0	4	30	122	10	6	35	58	0	0	0
75+	Rate	10.4	5.3	0.0	0.0	6.5	4.7	12.2	11.5	7.6	16.7	15.9	0.0	0.0	0.0
TOTAL	Cases	1,737	28	4	2	13	250	633	201	91	238	220	1	3	53
TOTAL	Rate	4.8	5.3	2.7	0.2	1.7	3.0	4.5	15.2	7.9	5.6	4.6	2.7	6.7	142.9
Abbreviations: Alta., Alberta; B.C., British Columbia; Man., Manitoba; N.B., New Brunswick; N.L., Newfoundland and Labrador; N.S., Nova Scotia; Nvt., Nunavut; N.W.T., Northwest Territories; Ont., Ontario; P.E.I., Prince Edward Island; Que., Quebec; Sask., Saskatchewan; Y.T., Yukon Table 3 Footnote a Source of denominator values for rate calculation: Statistics Canada, Demography Division, Demographic Estimates Section, July Population Estimates, 2006–2016 Updated postcensal estimates (Accessed 2017–10–18) Return to footnote a referrer

Table 4: Reported new active and re-treatment tuberculosis cases and incidence rate per 100,000 population, by origin – Canada and provinces/territories: 2016
Origin			Canada	Province/Territory
Origin			Canada	N.L.	P.E.I.	N.S.	N.B.	Que.	Ont.	Man.	Sask.	Alta.	North^{Footnote a}	B.C.
Canadian born	First Nations^{Footnote b}	Cases	209	3	0	0	1	4	7	123	49	20	2	n/a^{Footnote d}
	First Nations^{Footnote b}	Rate	23.8	14.3	0.0	0.0	5.3	3.4	2.7	90.4	38.9	13.5	9.1
	First Nations with status^{Footnote c}	Cases	208	3	0	0	1	4	7	122	49	20	2
	First Nations with status^{Footnote c}	Rate	25.2	6.2				4.6	3.3	78.2	31.9	15.9	7.0
	First Nations with status - on reserve^{Footnote c}	Cases	150	3	0	0	1	4	3	100	31	8	0
	First Nations with status - on reserve^{Footnote c}	Rate	34.1	16.5				7.0	3.1	107.9	41.2	10.4	0.0
	First Nations with status - off reserve^{Footnote c}	Cases	56	0	0	0	0	0	3	22	18	12	1
	First Nations with status - off reserve^{Footnote c}	Rate	14.5	0.0				0.0	2.6	34.7	22.9	24.6	8.4
	First Nations with status - unknown	Cases	2	0	0	0	0	0	1	0	0	0	1
	First Nations with status - unknown	Rate	Not applicable
	First Nations, non-status	Cases	1	0	0	0	0	0	1	0	0	0	0
	First Nations, non-status	Rate	n/a
	Métis^{Footnote b}	Cases	10	0	0	0	0	0	0	1	6	3	0
	Métis^{Footnote b}	Rate	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	9.8	2.5	0.0
	Inuit^{Footnote b}	Cases	114	20	0	0	1	42	2	0	0	0	49
	Inuit^{Footnote b}	Rate	170.1	285.7	0.0	0.0	100.0	280.0	50.0	0.0	0.0	0.0	132.4
	Total Indigenous^{Footnote b}	Cases	333	23	0	0	2	46	9	124	55	23	51
	Total Indigenous^{Footnote b}	Rate	23.5	62.2	0.0	0.0	7.4	25.3	2.4	53.9	29.4	8.5	79.7
	Non-Indigenous	Cases	135	1	1	0	5	44	48	9	5	19	3
	Non-Indigenous	Rate	0.6	0.2	0.7	0.0	0.7	0.6	0.5	1.0	0.6	0.6	6.4
	Total Canadian born	Cases	502	24	1	0	7	90	57	133	60	42	54	34
	Total Canadian born	Rates	1.8	4.6	0.7	0.0	1.0	1.3	0.6	12.1	5.7	1.2	48.9	1.0
Foreign born (by WHO epidemiological region)	AFR-High	Cases	114	1	0	0	2	26	44	9	4	23	1	4
	AFR-High	Rate	45.1	158.2	0.0	0.0	219.7	68.6	36.5	109.0	101.6	51.7	254.9	11.8
	AFR-Low	Cases	43	0	0	0	0	27	9	1	0	6	0	0
	AFR-Low	Rate	30.6	0.0	0	0.0	0.0	32.7	22.3	47.9	0.0	65.8	0.0	0.0
	AMR	Cases	56	0	0	0	1	26	19	3	0	5	0	2
	AMR	Rate	6.0	0.0	0.0	0.0	50.8	11.4	3.5	10.5	0.0	6.6	0.0	3.5
	EEUR	Cases	21	0	0	0	0	2	11	1	1	3	0	3
	EEUR	Rate	5.3	0.0	0.0	0.0	0.0	2.5	5.2	7.4	20.9	8.3	0.0	6.8
	EME & CEUR	Cases	38	0	0	0	0	8	21	2	0	1	0	6
	EME & CEUR	Rate	1.5	0.0	0.0	0.0	0.0	2.4	1.5	2.9	0.0	0.4	0.0	1.3
	EMR	Cases	140	1	0	0	0	20	75	0	0	35	0	9
	EMR	Rate	17.3	131.1	0.0	0.0	0.0	10.8	16.7	0.0	0.0	44.4	0.0	13.3
	SEAR	Cases	312	0	2	0	1	10	176	9	13	44	0	57
	SEAR	Rate	34.9	0.0	450.8	0.0	73.9	19.4	32.5	49.2	159.7	48.7	0.0	32.1
	WPR	Cases	475	2	1	2	2	40	195	38	13	78	2	102
	WPR	Rate	24.1	140.2	47.8	25.6	41.2	29.7	21.9	52.4	45.8	30.1	82.0	18.1
	Unknown	Cases	14	0	0	0	0	1	6	5	0	1	0	1
	Total Foreign born^{Footnote e}	Cases	1,213	4	3	2	6	160	556	68	31	196	3	184
	Total Foreign born^{Footnote e}	Rate	15.2	35.0	34.7	3.3	17.8	14.1	13.3	30.8	34.7	23.0	35.3	13.2
Unknown		Cases	22	0	0	0	0	0	20	0	0	0	0	2
Total		Cases	1,737	28	4	2	13	250	633	201	91	238	57	220
Total		Rate	4.8	5.3	2.7	0.2	1.7	3.0	4.5	15.2	7.9	5.6	47.9	4.6
Abbreviations: AFR-High, Africa high HIV prevalence; AFR-Low, Africa low HIV prevalence; Alta., Alberta; AMR, American Region – Latin American countries; B.C., British Columbia; CEUR, Central Europe; EEUR, Eastern European Region; EME, Established Market Economies; EMR, Eastern Mediterranean Region; Man., Manitoba; n/a, Not Available; N.B., New Brunswick; N.L., Newfoundland and Labrador; N.S., Nova Scotia; Ont., Ontario; P.E.I., Prince Edward Island; Que., Quebec; Sask., Saskatchewan; SEAR, South-East Asian Region; WPR, Western Pacific Region Source: Global tuberculosis report 2013, WHO report 2013. Geneva, World Health Organization (WHO/HTM/TB/2013.11) Table 3 Footnote a North includes Northwest Territories, Nunavut and Yukon Return to footnote a referrer Table 3 Footnote b Source of denominator values for rate calculation: Statistics Canada: Projections of the Aboriginal Population and Households in Canada, 2011 to 2036, Statistics Canada, Catalogue no. 91-552 Return to first footnote b referrer Table 3 Footnote c Source of denominator values for rate calculation for First Nations on- and off- reserve: Registered Indian Population, Household and Family Projections 2009-2034, AANDC, 2012. NOTE: First Nations population projections are only available for the Atlantic region which include N.L, N.B., N.S. and PEI combined. Therefore only one rate is given for the entire region Return to first footnote c referrer Table 3 Footnote d In 2016, British Columbia did not submit information on the Indigenous status breakdown. For origin status, cases were identified as either Canadian born or foreign born and therefore, no Indigenous-specific rates can be presented Return to footnote d referrer Table 3 Footnote e Source of denominator values for rate calculation for foreign born population: Statistics Canada–Custom Tabulation–2011 National Household Survey Return to footnote e referrer

Table 5: Tuberculosis incidence rates per 100,000 population, by origin – Canada, 2006–2016
Origin		Year
Origin		2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016^{Footnote a}
Canadian born	First Nation^{Footnote b}	28.7	28.4	28.2	26.9	22.2	19.1	21.2	20.4	18.0	15.2	23.8
	First Nations with status^{Footnote c}	29.2	28.9	28.1	27.4	22.8	20.0	22.3	22.1	19.1	16.3	25.2
	First Nations with status - on reserve^{Footnote c}	31.5	29.7	26.8	27.0	23.7	21.2	23.8	30.8	21.7	20.4	34.1
	First Nations with status - off reserve^{Footnote c}	26.3	24.2	28.0	24.3	20.0	16.4	18.7	11.4	15.2	11.1	14.5
	Métis^{Footnote b}	7.2	7.5	6.1	5.4	5.4	4.4	2.2	3.5	3.6	2.2	2.1
	Inuit^{Footnote b}	115.1	85.2	160.0	157.1	200.0	166.7	243.9	139.4	177.6	164.7	170.1
	Total Indigenous^{Footnote b}	25.4	23.9	26.2	24.9	23.6	20.7	24.4	19.9	20.0	17.1	23.5
	Non-Indigenous	0.9	0.7	0.9	1.0	0.7	0.7	0.7	0.6	0.6	0.6	0.6
	Total Canadian born	2.1	1.9	2.2	2.2	1.9	1.8	2.0	1.7	1.8	1.6	1.8
foreign born (by epidemiological region)	AFR-High	46.2	40.5	42.6	35.7	39.1	45.4	44.5	48.1	40.7	42.4	45.1
	AFR-Low	16.4	25.6	19.3	20.6	21.1	20.9	24.2	18.9	20.1	19.9	30.6
	AMR	5.7	9.2	7.5	6.7	7.5	7.6	5.6	5.5	4.6	6.6	6.0
	EEUR	4.8	7.0	4.7	4.4	5.2	4.6	3.7	2.9	2.9	5.9	5.3
	EME & CEUR	2.4	2.6	2.5	2.6	2.3	2.0	1.8	1.3	1.3	1.7	1.5
	EMR	17.0	15.8	14.3	14.2	12.2	14.1	15.5	15.8	13.1	12.9	17.3
	SEAR	32.0	29.8	30.1	29.2	30.5	32.6	31.8	39.2	33.6	34.4	34.9
	WPR	23.6	23.6	24.5	23.9	23.5	24.0	24.9	55.8	25.8	26.0	24.1
	Total foreign born^{Footnote d}	14.9	14.8	14.5	14.4	14.1	14.7	14.6	17.4	14.2	14.9	15.2
Total	Total Canada	5.1	4.8	4.9	4.9	4.7	4.7	4.9	4.7	4.5	4.6	4.8
Abbreviations: AFR-High, Africa high HIV prevalence; AFR-Low, Africa low HIV prevalence; AMR, American Region – Latin American countries; CEUR, Central Europe; EEUR, Eastern European Region; EME, Established Market Economies; EMR, Eastern Mediterranean Region; SEAR, South-East Asian Region; WPR, Western Pacific Region Source: Global tuberculosis report 2013, WHO report 2013. Geneva, World Health Organization (WHO/HTM/TB/2013.11) Table 5 Footnote a In 2016, British Columbia did not submit information on the Indigenous status breakdown. For origin status, cases were identified as either Canadian born or foreign born and therefore, no Indigenous-specific rates can be presented Return to footnote a referrer Table 5 Footnote b Source of denominator values for rate calculation: Statistics Canada: Projections of the Aboriginal Population and Households in Canada, 2011 to 2036, Statistics Canada, Catalogue no. 91-552 Return to first footnote b referrer Table 5 Footnote c Source of denominator values for rate calculation for First Nations on- and off- reserve: Registered Indian Population, Household and Family Projections 2009-2034, AANDC, 2012 Return to first footnote c referrer Table 5 Footnote d Source of denominator values for rate calculation for foreign born population: Statistics Canada–Custom Tabulation–2011 National Household Survey Return to footnote d referrer

Table 6: Reported new active and re-treatment tuberculosis cases and incidence rate per 100,000 population, by main diagnostic classification; Canada, 2006–2016^{Footnote a}
Main Diagnostic Classification			Reporting year
Main Diagnostic Classification			2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016
Respiratory	Primary^{Footnote b}	Cases	91	64	59	61	63	48	62	65	39	60	50
	Primary^{Footnote b}	Rate	0.3	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.2	0.1
	Pulmonary^{Footnote c}	Cases	1,132	1,034	1,146	1,125	1,043	1,099	1,149	1,125	1,110	1,084	1,196
	Pulmonary^{Footnote c}	Rate	3.5	3.1	3.4	3.3	3.1	3.2	3.3	3.2	3.1	3.0	3.3
	Other respiratory^{Footnote d}	Cases	85	94	78	97	102	83	96	90	86	77	103
	Other respiratory^{Footnote d}	Rate	0.3	0.3	0.2	0.3	0.3	0.2	0.3	0.3	0.2	0.2	0.3
Nonrespiratory	Miliary	Cases	10	11	14	12	11	13	8	12	11	17	17
	Miliary	Rate	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	Central nervous system	Cases	16	22	11	14	24	21	22	27	19	23	25
	Central nervous system	Rate	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1
	Peripheral lymph nodes	Cases	192	202	181	207	198	222	204	180	209	223	198
	Peripheral lymph nodes	Rate	0.6	0.6	0.5	0.6	0.6	0.6	0.6	0.5	0.6	0.6	0.5
	Other^{Footnote e}	Cases	127	148	153	138	146	135	159	152	140	158	148
	Other^{Footnote e}	Rate	0.4	0.5	0.5	0.4	0.4	0.4	0.5	0.4	0.4	0.4	0.4
TOTAL		Cases	1,653	1,575	1,642	1,654	1,587	1,621	1,700	1,651	1,614	1,642	1,737
TOTAL		Rate	5.1	4.8	4.9	4.9	4.7	4.7	4.9	4.7	4.5	4.6	4.8
Table 6 Footnote a Source of denominator values for rate calculation: Statistics Canada, Demography Division, Demographic Estimates Section, July Population Estimates, 2006–2016 Updated postcensal estimates (Accessed 2017–10–18) Return to footnote a referrer Table 6 Footnote b Primary includes primary respiratory tuberculosis and tuberculous pleurisy in primary progressive tuberculosis (ICD-9 codes 010.0-010.9; ICD-10 codes A15.7 and A16.7) Return to footnote b referrer Table 6 Footnote c Pulmonary includes tuberculosis of the lungs and conducting airways which includes tuberculous fibrosis of the lung, tuberculous bronchiectasis, tuberculous pneumonia, tuberculous pneumothorax, isolated tracheal or bronchial tuberculosis, and tuberculous laryngitis (ICD-9 codes 011-011.9, 012.2, 012.3; ICD-10 codes A15.0-A15.3, A15.5, A15.9, A16.0-A16.2, A16.4, A16.9) Return to footnote c referrer Table 6 Footnote d Other respiratory includes tuberculous pleurisy (non-primary) and tuberculosis of the intrathoracic lymph nodes, mediastinum, nasopharynx, nose (septum), and sinus (any nasal) (ICD-9 codes: 012.0, 012.1 and 012.8; ICD-10 codes: A15.4, A15.6, A15.8, A16.3, A16.5, A16.8) Return to footnote d referrer Table 6 Footnote e Other includes tuberculosis of the intestines, peritoneum and mesenteric glands, bones and joints, genitourinary system, skin, eye, ear, thyroid, adrenal, and spleen Return to footnote e referrer

Table 7: Reported new active and re-treatment tuberculosis cases and incidence rate per 100,000 population, by main diagnostic classificaton – Canada and provinces/terrtories, 2016^{Footnote a}
Main Diagnostic Classification			Canada	Province/territory
Main Diagnostic Classification			Canada	N.L.	P.E.I.	N.S.	N.B.	Que.	Ont.	Man.	Sask.	Alta.	B.C.	Y.T.	N.W.T.	Nvt.
Respiratory	Primary^{Footnote b}	Cases	50	0	0	0	4	3	7	21	6	5	0	0	0	4
	Primary^{Footnote b}	Rate	0.1	0.0	0.0	0.0	0.5	0.0	0.1	1.6	0.5	0.1	0.0	0.0	0.0	10.8
	Pulmonary^{Footnote c}	Cases	1,196	26	2	2	7	185	418	131	57	154	167	1	1	45
	Pulmonary^{Footnote c}	Rate	3.3	4.9	1.3	0.2	0.9	2.2	3.0	9.9	5.0	3.6	3.5	2.7	2.2	121.4
	Other respiratory^{Footnote d}	Cases	103	0	0	0	0	17	32	13	9	19	10	0	1	2
	Other respiratory^{Footnote d}	Rate	0.3	0.0	0.0	0.0	0.0	0.2	0.2	1.0	0.8	0.4	0.2	0.0	2.2	5.4
Nonrespiratory	Miliary	Cases	17	1	0	0	2	4	6	1	0	3	0	0	0	0
	Miliary	Rate	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0
	Central nervous system	Cases	25	1	0	0	0	4	10	1	1	7	1	0	0	0
	Central nervous system	Rate	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0
	Peripheral lymph nodes	Cases	198	0	2	0	0	14	90	22	12	34	23	0	0	1
	Peripheral lymph nodes	Rate	0.5	0.0	1.3	0.0	0.0	0.2	0.6	1.7	1.0	0.8	0.5	0.0	0.0	2.7
	Other^{Footnote e}	Cases	148	0	0	0	0	23	70	12	6	16	19	0	1	1
	Other^{Footnote e}	Rate	0.4	0.0	0.0	0.0	0.0	0.3	0.5	0.9	0.5	0.4	0.4	0.0	2.2	2.7
TOTAL		Cases	1,737	28	4	2	13	250	633	201	91	238	220	1	3	53
TOTAL		Rate	4.8	5.3	2.7	0.2	1.7	3.0	4.5	15.2	7.9	5.6	4.6	2.7	6.7	142.9
Abbreviations: Alta., Alberta; B.C., British Columbia; Man., Manitoba; N.B., New Brunswick; N.L., Newfoundland and Labrador; N.S., Nova Scotia; Nvt., Nunavut; N.W.T., Northwest Territories; Ont., Ontario; P.E.I., Prince Edward Island; Que., Quebec; Sask., Saskatchewan; Y.T., Yukon Table 7 Footnote a Source of denominator values for rate calculation: Statistics Canada, Demography Division, Demographic Estimates Section, July Population Estimates, 2006–2016 Updated postcensal estimates (Accessed 2017–10–18) Return to footnote a referrer Table 7 Footnote b Primary includes primary respiratory tuberculosis and tuberculous pleurisy in primary progressive tuberculosis (ICD-9 codes 010.0-010.9; ICD-10 codes A15.7 and A16.7) Return to footnote b referrer Table 7 Footnote c Pulmonary includes tuberculosis of the lungs and conducting airways which includes tuberculous fibrosis of the lung, tuberculous bronchiectasis, tuberculous pneumonia, tuberculous pneumothorax, isolated tracheal or bronchial tuberculosis, and tuberculous laryngitis (ICD-9 codes 011-011.9, 012.2, 012.3; ICD-10 codes A15.0-A15.3, A15.5, A15.9, A16.0-A16.2, A16.4, A16.9) Return to footnote c referrer Table 7 Footnote d Other respiratory includes tuberculous pleurisy (non-primary) and tuberculosis of the intrathoracic lymph nodes, mediastinum, nasopharynx, nose (septum), and sinus (any nasal) (ICD-9 codes: 012.0, 012.1 and 012.8; ICD-10 codes: A15.4, A15.6, A15.8, A16.3, A16.5, A16.8) Return to footnote d referrer Table 7 Footnote e Other includes tuberculosis of the intestines, peritoneum and mesenteric glands, bones and joints, genitourinary system, skin, eye, ear, thyroid, adrenal, and spleen Return to footnote e referrer

Table 8: Treatment outcome – Canada and provinces/territories: 2015
Province/Territory	Canada	Treatment Outcome
Province/Territory	Canada	Cured^{Footnote a}	Treatment completed without culture^{Footnote b}	Death during treatment^{Footnote c}	Treatment ongoing^{Footnote d}	Transferred	Other	Absconded^{Footnote e}	Unknown	Treatment discontinued due to adverse event^{Footnote f}	Failure^{Footnote g}
N.L.	33	17	14	2	0	0	0	0	0	0	0
P.E.I.	3	1	2	0	0	0	0	0	0	0	0
N.S.	6	0	4	1	0	1	0	0	0	0	0
N.B.	6	1	3	1	1	0	0	0	0	0	0
Que.	244	50	156	18	11	3	5	0	0	1	0
Ont.	597	0	498	59	15	8	0	3	14	0	0
Man.	158	58	75	12	2	2	1	7	0	1	0
Sask.	70	59	0	3	0	0	7	0	0	1	0
Alta.	210	77	106	11	2	7	4	2	0	1	0
B.C.	263	24	188	34	0	9	3	3	2	0	0
Y.T.	3	0	2	1	0	0	0	0	0	0	0
N.W.T.	5	5	0	0	0	0	0	0	0	0	0
Nvt.	44	34	6	0	0	0	2	2	0	0	0
CANADA	1,642	326	1,054	142	31	30	22	17	16	4	0
Abbreviations: Alta., Alberta; B.C., British Columbia; Man., Manitoba; N.B., New Brunswick; N.L., Newfoundland and Labrador; N.S., Nova Scotia; Nvt., Nunavut; N.W.T., Northwest Territories; Ont., Ontario; P.E.I., Prince Edward Island; Que., Quebec; Sask., Saskatchewan; Y.T., Yukon Table 8 Footnote 1 Treatment completion and culture-negative samples taken at the end of treatment and on at least one previous occasion Return to footnote a referrer Table 8 Footnote 1 Treatment completed, but case does not meet the criteria to be classified as cured or treatment failure Return to footnote b referrer Table 8 Footnote 1 Death before cured or treatment completion, irrespective of cause Return to footnote c referrer Table 8 Footnote 1 Patient still on treatment at 12 months and at 24 months for MDR-TB cases without any other outcome during treatment Return to footnote d referrer Table 8 Footnote 1 Lost to follow-up before completion of 80% of recommended doses Return to footnote e referrer Table 8 Footnote 1 This includes adverse drug reaction, sensitivity to drugs, or any other case where the patient was unable to tolerate the prescribed medication Return to footnote f referrer Table 8 Footnote 1 Positive sputum cultures after four or more months of treatment or two positive sputum cultures in different months during the last three months of treatment, even if the final culture is negative and no further treatment is planned Return to footnote g referrer

Previous page

Table of contents

Next page

Language selection

Search